Cysteine-lowering Treatment With Mesna

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 2, 2020

Primary Completion Date

October 21, 2021

Study Completion Date

October 21, 2021

Conditions
ObesityDrug Effect
Interventions
DRUG

Mesna

Administration of a single oral dose, using film-coated tablets of either 400 mg or 600 mg or a combination of maximum 3 tablets up to a maximum of 1600 mg

Trial Locations (1)

Unknown

University of Oslo, Oslo

All Listed Sponsors
collaborator

Oslo University Hospital

OTHER

collaborator

University of Oxford

OTHER

lead

University of Oslo

OTHER

NCT04449536 - Cysteine-lowering Treatment With Mesna | Biotech Hunter | Biotech Hunter